Aloe arborescens aqueous gel extract alters the activities of key hepatic enzymes and blood concentration of triglycerides, glucose and insulin in alloxan-induced diabetic rats

African Journal of Biotechnology

Volumn 10, Issue 20, 2011, Pages 4242-4248

  Mogale, Motetelo Alfred ^a   Lebelo, Sogolo Lucky ^b   Shai, Leshweni Jeremia ^c   Eloff, Jacobus Nicholaas ^d  

^a UNIVERSITY OF LIMPOPO   (South Africa)

^b UNIVERSITY OF SOUTH AFRICA   (South Africa)

^c TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

^d UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Alloxan; Aloe arborescens; Antidiabetic activity; Diabetic rats; Hepatic enzymes

Indexed keywords

ALOE ARBORESCENS EXTRACT; ANTIDIABETIC AGENT; GLUCOKINASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ALOE; ALOE ARBORESCENS; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FLUID INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PLANT LEAF; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ALOE ARBORESCENS; RATTUS;

EID: 79957667568     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Agius L (2007). New hepatic targets for glycemic control in diabetes. Best. Pract. Res. Clin. Endocrinol. Method, 4: 587-605.
2. Al-Awadi F, Fatania H, Shamte U (1991). The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res. Clin. Exp. 18(4): 163-168
3. Bastaki S (2005). Diabetes mellitus and its treatment. Int. J. Diabetes. Method, 13: 111-134.
4. Beppu H, Nakamura Y, Fugita K (1993). Hypoglycemic and antidiabetic effects in mice of Aloe arborescens Miller var. natalensis berger. Phytother. Res. 7: 37-42.
5. Beppu H, Koike T, Shimpo K, Chihara T, Hoshino M, Ida C, Kuzuya H (2003). Radial-scarvenging effects of Aloe arborescens Miller. on prevention of pancreatic islet B cell destruction in rats. J. Ethnopharmacol. 89: 37-45.
6. Beppu H, Shimpo K, Chihara T, Kaneko T, Tamai I, Yamaji S, Ozaki S, Kuzuya H Sonoda S (2006). Antidiabetic effects of dietary administration of Aloe arborescens Miller. components on multiple low-dose streptozotocin-induced diabetes in mice: Investigation on hypoglycemic action and systemic absorption dynamics of aloe components. J. Ethnopharmacol. 103: 468-477.
7. Bnouham M, Ziyyat A, Mekhfi H, Tahri A Legssyer A (2006). Medicinal plants with potential antidiabetic activity-A review of ten years of herbal medicine research (1990-2000). Int. J. Diabetes. Method, 14: 1-25.
8. Chacko SM, Sabitha T, Kuttan R (2008). Amelioration of alloxaninduced hyperglycaemia by Aloe arborescens Miller. and its possible mechanism. Pharmacologyonline, 2: 112-125.
9. Cheng AYY, Fantus G (2005). Oral antihyperglycemic therapy for type 2 diabetes mellitus. Can. Med. Assoc. J. 172: 213-226.
10. Chapman E, Wong C (2002). A pH sensitive colorometric assay for the high-throughput screening of enzyme inhibitors and substrates: A case study using kinases. Bioorg. Med. Chem. 10: 551-555.
11. Chattopadhyay RR (1998). Possible mechanism of antihyperglycemic effect of Gymnema sylvestre leaf extract, part 1. Gen. Pharmacol. 31: 495-496.
12. Day C, Bailey CJ (2006). Preclinical and clinical methods for evaluating antidiabetic activity of plants. In: Soumyanath A, (Ed). Traditional Medicines for Modern Times. Antidiabetic Plants. Taylor and Francis Group, New York, pp. 83-98.
13. Dhandapani S, Ramasamy SV, Rajagopal S, Namasivayam N (2002). Hypolipidemic effect of Cuminum cyminum L. on alloxan-induced diabetic rats. Pharmacol. Res. 46 (3): 251-255.
14. Fiske CH, Subbarow J (1925). The colorimetric determination of phosphorus. J. Biol. Chem. 66: 375-400.
15. Frode TS, Medeiros YS (2006). Animal models to test drugs with potential antidiabetic activity. J. Ethnopharmacol. 115: 173-183.
16. Grover JK, Yadav S, Vats V (2002). Medicinal plants of India with antidiabetic potential. J. Ethnopharmacol. 81: 81-100.
17. Hikino H, Takahashi M, Murakami M, Konno C, Mirin Y, Karikura M, Hayashi T (1986). Isolation and hypoglycemic activity of arborans A and B, glycans of Aloe arborescens var. natalensis leaves. Int. J. Crude Drug Res. 24: 183-186.
18. Jayawardena MHS, de Alwis NMW, Hettigoda V, Fernando DJS (2005). A double blind randomized placebo controlled cross over study of a herbal preparation containing Salacia reticulata in the treatment of type 2 diabetes. J. Ethnopharmacol. 96: 215-218.
19. Katerere DR, Eloff JN (2005). Management of diabetes in African traditional medicine in Soumyanath, A (Ed.)Traditional Medicines for modern times. Antidiabetic Plants, CRC Taylor and Francis, London. 6: 203-220.
20. Klover PJ, Mooney RA (2004). Hepatocytes: critical for glucose homeostasis. Int. J. Biochem. Cell Biol. 36: 753-758.
21. Kusano S, Abe H (2000). Antidiabetic activity of white skinned sweet potato (Ipomoea batatas L.) in obese Zucker fatty rats). Biol. Pharm. Bull. 23: 23-26.
22. Kwiterovich PO (2000). The metabolic pathways of high density lipoproteins, low density lipoproteis and triglycerides: A Current Review, Am. J. Cardiol. 86(suppl), 5L-10L.
23. Lowry OH, Rosenbrough NF, Farr AL, Randall JL (1951). Protein measurement with the Folin Phenol reagent. J. Biol. Chem. 193: 265-275.
24. Marles RJ, Farnsworth NR (1995). Antidiabetic plants and their active constituents. Phytomed. 2: 137-189.
25. Mlinar B, Marc J, Janez A, Pfeifer M (2007). Molecular mechanisms of insulin resistance and associated diseases. Clin. Chim. Acta. 375: 20-35.
26. Mooradian A (2009). Dyslipidemia in type 2 diabetes mellitus. Endocrinol. Met. 5(3): 150-159.
27. Ooi TK, Ooi DS (1998). The atherogenic significance of an elevated plasma triglyceride level. Crit. Rev. Clin. Lab. Sci. 35(6): 489-516.
28. Pari L, Satheesh MA (2004). Antidiabetic activity of Boerhaavia diffusa L: effect on hepatic key enzymes in experimental diabetes. J. Pharmacol. 91(1): 109-113.
29. Pari L, Satheesh MA (2006). Effects of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin and nicotinamide induced diabetic rats. Life Sci. 79(7): 641-645.
30. Reynolds T, Dweck AC (1999). Aloe vera leaf gel: A review update. J. Ethnopharmacol. 68: 3-37.
31. Smith C, Marks AD, Lieberman M (2005). Marks's Basic Medical Biochemistry: A Clinical Approach, second Ed. Lippincott Williams & Wilkins, Baltimore.
32. Smith CF, Klopper RR, Crouch NR (2008). Aloe arborescens (Asphodelaceae: Aloaceae) and CITES. Haseltonia, 14: 189-198.
33. Sniderman AD, Lamarche B, Tilley J, Seccombe D, Froflich J (2002). ypertriglyceridemic hyperapo B in type 2 diabetes mellitus. Diabetes Care, 25(3): 579-582.
34. Szudelski T (2001). The mechanism of Alloxan and Streptozotocin action in B cells of the rat pancreas. Phys. Res. 50: 537-46.
35. Tanira MOM, (1994). Antidiabetic medicinal plants: a review of the present status and future directions. Int. J. Diabetes, 2(1): 15-22.
36. van Wyk B-E, Smith G (2004). Guide to aloes of South Africa, second Ed. Briza Publications, Pretoria.
37. Zhang X, Liang W, Mao Y, Li Yang, Y, Tan H (2007). Hepatic glucokinase activity is the primary defect in alloxan-induced experimental diabetes. Biomed. Pharmacol. 20: 1-7.